Press room

Prof. Pellicer: “This congress will allow us to study how to stem declining birth rates”
24 February 2022
Prof. Pellicer: “This congress will allow us to study how to stem declining birth rates”

At the meeting, we will discuss current maternity habits, public awareness of science, ethics and obstacles to accessing reproductive treatments, among other issues. Maria Neira, Director of the WHO Department of Public Health and Environment, will speak about the impact of COVID-19 on Assisted Reproduction. VALENCIA, 24 FEBRUARY 2022 The World Symposium on Assisted Reproduction,… View Article

pregnancy rates embryos
9 February 2022
Assisted hatching increases the gestation rate of embryos after collapse to 60%.

It is a tool for embryo optimisation that improves the reproductive outcomes of patients in their treatments. The study was recently presented at the 11th ASEBIR Congress, held in Toledo, where it received an award. VALENCIA, 9 FEBRUARY 2022 Embryos and the whole process that they follow until they implant in the maternal uterus is… View Article

reproductive genetics
19 November 2021
Reproductive genetics: the accuracy of non-invasive preimplantation testing, to be debated

Reproductive genetics is one of the essential topics in ART today. Non-invasive pre-implantation genetic testing – are we ready? This is the interesting question posed at the round table discussion moderated by Dr. Nicolás Prados, Director of IVI’s IVF laboratory, on the last day of the 9th edition of the IVIRMA Congress. The use of… View Article

ovarian ageing
18 November 2021
Ovarian ageing may be associated with mitochondrial dysfunction

As women delay becoming mothers due to demographic and socioeconomic factors, reproductive ageing and associated ovarian ageing are becoming increasingly common causes of infertility. With age, eggs decrease in quality and quantity, often leading to reproductive problems. “It is important to note that ageing disorders are often associated with mitochondrial dysfunction, as well as disturbances… View Article

IVIRMA Congress
18 November 2021
The 9th International IVIRMA Congress brings together the main researchers in assisted reproduction worldwide

The ninth edition of the International Congress organized by IVIRMA Global will take place from  Monday 15 to Friday 19 November. Considered a benchmark in the Assisted Reproduction sector, each edition brings together leading experts in the reproductive field. For the first time, the meeting will be held online, due to the health situation. This… View Article

covid-19 fertility IVI
19 April 2021
IVI study shows that COVID-19 does not affect female fertility

The presence of virus receptors in the ovary justifies the importance of analysing how SARS-CoV-2 affects ovarian reserve. No decrease in Anti-Müllerian hormone (AMH) levels was observed in women who survived the disease and participated in the study.   Despite the overwhelming magnitude of this pandemic and its global prevalence, information on the effects of… View Article

autism sperm IVI
2 April 2021
Likelihood of autism can be predicted before birth, reveals IVI study

The results obtained from the paternal sperm samples analysed show an accuracy of 90% Previous studies have already shown that children can inherit a significant predisposition to this disorder from their parents and that men have a greater influence than women on their children’s risk of autism   The incidence of autism spectrum disorder (ASD),… View Article

endometriosis vitrification
11 March 2021
Women under 35 with endometriosis achieve a 95% success rate after vitrification of 20 oocytes

This research aims to help fertility specialists and endometriosis patients set realistic expectations about their chances of reproductive success. After previous ovarian surgery, fewer oocytes will be retrieved, which may have a negative impact on future chances of achieving pregnancy. March is Endometriosis Awareness Month, a disease still ignored although it concerns 10% of women… View Article

blood type Covid-19
26 January 2021
Patients with blood group type 0 and Rh-positive may have greater protection against COVID-19

A sample of 6,140 patients shows that the positive rate does not vary significantly with age or gender. Previous studies and their results lead to caution when taking blood group as a factor to identify the risk of developing COVID-19, as must first urgently verify its real reliability as a determining element in this association…. View Article


  • Ricardo Pedrós
  • Lucía Renau
  • Email:
  • Phone number: (0034) 96 317 36 10
  • Calle Colón, 1 - 46004 (Valencia)


Last update
February 2020

Download PDF

Back to toparrow_drop_up